Published in Int Immunol on July 01, 1998
Death, autoantigen modifications, and tolerance. Arthritis Res (2000) 1.75
Extracellular matrix remodeling: the common denominator in connective tissue diseases. Possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure. Assay Drug Dev Technol (2012) 1.30
Identification of tumor-associated, MHC class II-restricted phosphopeptides as targets for immunotherapy. Proc Natl Acad Sci U S A (2009) 1.19
Autoantigenesis: the evolution of protein modifications in autoimmune disease. Curr Opin Immunol (2011) 1.03
Comparative quantitative mass spectrometry analysis of MHC class II-associated peptides reveals a role of GILT in formation of self-peptide repertoire. PLoS One (2010) 0.98
Role of α-synuclein in inducing innate and adaptive immunity in Parkinson disease. J Parkinsons Dis (2015) 0.93
β cell ER stress and the implications for immunogenicity in type 1 diabetes. Front Cell Dev Biol (2015) 0.90
Activated antigen-presenting cells select and present chemically modified peptides recognized by unique CD4 T cells. Proc Natl Acad Sci U S A (2005) 0.86
The Repertoires of Peptides Presented by MHC-II in the Thymus and in Peripheral Tissue: A Clue for Autoimmunity? Front Immunol (2013) 0.81
Environmental Factors Contribute to β Cell Endoplasmic Reticulum Stress and Neo-Antigen Formation in Type 1 Diabetes. Front Endocrinol (Lausanne) (2017) 0.75
T-cell-receptor affinity and thymocyte positive selection. Nature (1996) 4.96
Sequence of an HLA-DR alpha-chain cDNA clone and intron-exon organization of the corresponding gene. Nature (1982) 2.18
The impact of duration versus extent of TCR occupancy on T cell activation: a revision of the kinetic proofreading model. Immunity (2001) 2.02
Qualitative and quantitative differences in T cell receptor binding of agonist and antagonist ligands. Immunity (1999) 1.99
S-layer protein of Lactobacillus acidophilus ATCC 4356: purification, expression in Escherichia coli, and nucleotide sequence of the corresponding gene. J Bacteriol (1993) 1.53
Replication of the A7(74) strain of Semliki Forest virus is restricted in neurons. Virology (1993) 1.50
Failure or success in the restoration of virus-specific cytotoxic T lymphocyte response defects by dendritic cells. J Immunol (1988) 1.43
Experimental encephalomyelitis modulates inositol and taurine in the spinal cord of Biozzi mice. Magn Reson Med (1994) 1.40
Factors affecting reconstitution of the T cell compartment in allogeneic haematopoietic cell transplant recipients. Bone Marrow Transplant (2003) 1.37
N-linked glycan modification on antigen-presenting cells restores an allospecific cytotoxic T cell response. J Exp Med (1990) 1.34
Genetic analysis of acidocin B, a novel bacteriocin produced by Lactobacillus acidophilus. Microbiology (1995) 1.28
Isolation and characterization of mutants of Aspergillus niger deficient in extracellular proteases. Mol Gen Genet (1992) 1.17
A cDNA clone encoding the mouse Qa-1a histocompatibility antigen and proposed structure of the putative peptide binding site. J Immunol (1993) 1.16
Disease inhibition by major histocompatibility complex binding peptide analogues of disease-associated epitopes: more than blocking alone. J Exp Med (1992) 1.12
Selective association of multiple sclerosis with infectious mononucleosis. Mult Scler (2008) 1.12
Gray matter pathology in (chronic) MS: modern views on an early observation. J Neurol Sci (2009) 1.11
Leishmania infantum-specific T cell lines derived from asymptomatic dogs that lyse infected macrophages in a major histocompatibility complex-restricted manner. Eur J Immunol (1995) 1.11
Antigen processing by endosomal proteases determines which sites of sperm-whale myoglobin are eventually recognized by T cells. Eur J Immunol (1991) 1.08
Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein. Blood (2001) 1.08
High IL-13 production by human neonatal T cells: neonate immune system regulator? Eur J Immunol (2001) 1.07
Abolition of specific immune response defect by immunization with dendritic cells. Nature (1985) 1.05
Demonstration of placental and placental-like alkaline phosphatase in non-malignant human tissue extracts using monoclonal antibodies in an enzyme immunoassay. Clin Chim Acta (1984) 1.04
T cell reactivity to an epitope of the mycobacterial 65-kDa heat-shock protein (hsp 65) corresponds with arthritis susceptibility in rats and is regulated by hsp 65-specific cellular responses. Eur J Immunol (1991) 1.03
Similar antigenic surfaces, rather than sequence homology, dictate T-cell epitope molecular mimicry. Proc Natl Acad Sci U S A (1995) 1.01
The elongation factor Tu.kirromycin complex has two binding sites for tRNA molecules. EMBO J (1982) 0.99
Expression of alphaB-crystallin in glia cells during lesional development in multiple sclerosis. J Neuroimmunol (1997) 0.97
Characterization of the cellular and cytokine response in the central nervous system following Semliki Forest virus infection. J Neuroimmunol (1997) 0.97
Optic neuritis in chronic relapsing experimental allergic encephalomyelitis in Biozzi ABH mice: demyelination and fast axonal transport changes in disease. J Neuroimmunol (1998) 0.97
Lack of expression of HLA-ABC antigens in choriocarcinoma and other human tumor cell lines. Natl Cancer Inst Monogr (1982) 0.97
Cytomegalovirus-specific cellular immune responses and viremia in recipients of allogeneic stem cell transplants. J Infect Dis (2001) 0.96
EBV-induced expression and HLA-DR-restricted presentation by human B cells of alpha B-crystallin, a candidate autoantigen in multiple sclerosis. J Immunol (1999) 0.96
Activation of virus-specific major histocompatibility complex class II-restricted CD8+ cytotoxic T cells in CD4-deficient mice. Eur J Immunol (1995) 0.94
Role of virus-specific CD4+ cytotoxic T cells in recovery from mouse hepatitis virus infection. Immunology (1996) 0.94
Reconstitution of Semliki forest virus infected mice, induces immune mediated pathological changes in the CNS. Clin Exp Immunol (1983) 0.93
Sequences derived from the highly antigenic VP1 region 140 to 160 of foot-and-mouth disease virus do not prime for a bovine T-cell response against intact virus. J Virol (1995) 0.92
Anti-alpha B-crystallin immunoreactivity in inflammatory nervous system diseases. J Neurol (2000) 0.92
Localization of a T-cell epitope within the nucleocapsid protein of avian coronavirus. Immunology (1991) 0.91
Non-human primate models of multiple sclerosis. Immunol Rev (2001) 0.91
Inhibition of experimental autoimmune encephalomyelitis by MHC class II binding competitor peptides depends on the relative MHC binding affinity of the disease-inducing peptide. J Immunol (1994) 0.89
Identification of non-naïve CD4+CD45RA+ T cell subsets in adult allogeneic haematopoietic cell transplant recipients. Bone Marrow Transplant (2003) 0.89
Identification of an H-2 Kb-presented Moloney murine leukemia virus cytotoxic T-lymphocyte epitope that displays enhanced recognition in H-2 Db mutant bm13 mice. J Virol (1994) 0.89
Autoantibodies against alpha B-crystallin, a candidate autoantigen in multiple sclerosis, are part of a normal human immune repertoire. Mult Scler (2006) 0.89
Predominance of MHC class II-restricted CD4+ cytotoxic T cells against mouse hepatitis virus A59. Immunology (1995) 0.89
Cell biology of autoimmune diseases. Int Rev Cytol (1998) 0.88
Differential expression of stress proteins in human adult astrocytes in response to cytokines. J Neuroimmunol (2000) 0.88
The protective effects of omega-6 fatty acids in experimental autoimmune encephalomyelitis (EAE) in relation to transforming growth factor-beta 1 (TGF-beta1) up-regulation and increased prostaglandin E2 (PGE2) production. Clin Exp Immunol (2000) 0.88
Role of spleen macrophages in innate and acquired immune responses against mouse hepatitis virus strain A59. Immunology (1997) 0.87
Distinct conformations of a peptide bound to HLA-DR1 or DRB5*0101 suggested by molecular modelling. Int Immunol (1996) 0.87
Adjuvant arthritis and immunity to the mycobacterial 65 kDa heat shock protein. Int Immunol (1992) 0.87
Modulation of experimental autoimmunity: treatment of adjuvant arthritis by immunization with a recombinant vaccinia virus. Infect Immun (1991) 0.87
N-terminal elongation of a peptide determinant beyond the first primary anchor improves binding to H-2 I-Ad and HLA-DR1 by backbone-dependent and aromatic side chain-dependent interactions, respectively. Eur J Immunol (1999) 0.86
Modulation of the immune response with T-cell epitopes: the ultimate goal for specific immunotherapy of autoimmune disease. Immunology (1994) 0.86
Sequence-specific oligonucleotide probing for MICB alleles reveals associations with MICA and HLA-B. Immunogenetics (2000) 0.85
BLBP-expression in astrocytes during experimental demyelination and in human multiple sclerosis lesions. Brain Behav Immun (2011) 0.85
Encephalitogenic and immunogenic potential of the stress protein alphaB-crystallin in Biozzi ABH (H-2A(g7)) mice. J Neuroimmunol (2000) 0.84
CDR1 T-cell receptor beta-chain peptide induces major histocompatibility complex class II-restricted T-T cell interactions. Proc Natl Acad Sci U S A (1994) 0.84
Targeting the tetraspanin CD81 blocks monocyte transmigration and ameliorates EAE. Neurobiol Dis (2008) 0.84
A novel first primary anchor extends the MHC class II I-Ad binding motif to encompass nine amino acids. Int Immunol (1997) 0.84
Transient virus infection and multiple sclerosis. Rev Med Virol (2000) 0.84
T cell-stimulatory fragments of foot-and-mouth disease virus released by mild treatment with cathepsin D. J Gen Virol (1994) 0.84
Comparison of peptides eluted from the groove of HLA-B27 from Salmonella infected and non-infected cells. Clin Rheumatol (1996) 0.83
Differential activation of mouse hepatitis virus-specific CD4+ cytotoxic T cells is defined by peptide length. Immunology (1995) 0.83
Presentation of alpha B-crystallin to T cells in active multiple sclerosis lesions: an early event following inflammatory demyelination. J Immunol (2000) 0.83
A novel population of CD4+CD56+ myelin-reactive T cells lyses target cells expressing CD56/neural cell adhesion molecule. J Immunol (1996) 0.83
Cross-reactivity between related sequences found in Acinetobacter sp., Pseudomonas aeruginosa, myelin basic protein and myelin oligodendrocyte glycoprotein in multiple sclerosis. J Neuroimmunol (2003) 0.82
A canine CD8+ cytotoxic T-cell line specific for Leishmania infantum-infected macrophages. Tissue Antigens (1994) 0.82
Stress, the immune system and vulnerability to degenerative disorders of the central nervous system in transgenic mice expressing glucocorticoid receptor antisense RNA. Brain Res Brain Res Rev (2001) 0.82
Activated rat T cells synthesize and express functional major histocompatibility class II antigens. Immunology (1995) 0.82
The phlebotomine fauna (Diptera: Psychodidae) of the eastern coast of Tunisia. J Med Entomol (2009) 0.81
The hippocampal fimbria of cuprizone-treated animals as a structure for studying neuroprotection in multiple sclerosis. Inflamm Res (2011) 0.81
FTY720 on the way from the base camp to the summit of the mountain: relevance for remyelination. Mult Scler (2012) 0.81
Stress, glucocorticoids and the susceptibility to develop autoimmune disorders of the central nervous system. Neurol Sci (2001) 0.81
Efficient recognition by rat T cell clones of an epitope of mycobacterial hsp 65 inserted in Escherichia coli outer membrane protein PhoE. Eur J Immunol (1990) 0.81
Multiple sclerosis: variations on a theme. Immunol Today (1997) 0.81
Brain lipid binding protein (FABP7) as modulator of astrocyte function. Physiol Res (2011) 0.81
The sphingosine 1-phosphate receptor agonist FTY720 is neuroprotective after cuprizone-induced CNS demyelination. Br J Pharmacol (2014) 0.81
The role of anti-myelin (auto)-antibodies in the phagocytosis of myelin by macrophages. J Neuroimmunol (1999) 0.80
Prediction of an HLA-B44 binding motif by the alignment of known epitopes and molecular modeling of the antigen binding cleft. Immunogenetics (1994) 0.80
Specific tolerance induction and transplantation: a single-day protocol. Blood (1997) 0.79
Late rather than early responses of human dendritic cells highlight selective induction of cytokines, chemokines and growth factors by probiotic bacteria. Benef Microbes (2010) 0.79
Prevention of experimental autoimmune encephalomyelitis in Lewis rats by a novel fungal source of gamma-linolenic acid. Br J Nutr (1995) 0.79
T- and B-cell nonresponsiveness to self-alphaB-crystallin in SJL mice prevents the induction of experimental allergic encephalomyelitis. Cell Immunol (2000) 0.79
T cell receptor binding kinetics and special role of Valpha in T cell development and activation. Immunol Res (2000) 0.79
Abundant extracellular myelin in the meninges of patients with multiple sclerosis. Neuropathol Appl Neurobiol (2008) 0.79
SiPep: a system for the prediction of tissue-specific minor histocompatibility antigens. Int J Immunogenet (2006) 0.79
Heat-shock proteins as antigens in autoimmunity. Biochem Soc Trans (1991) 0.78
Antibodies to myelin oligodendrocyte glycoprotein as a biomarker in multiple sclerosis--are we there yet? Mult Scler (2007) 0.78
Differential rat T cell recognition of cathepsin D-released fragments of mycobacterial 65 kDa heat-shock protein after immunization with either the recombinant protein or whole mycobacteria. Int Immunol (1994) 0.78
A role for alpha4-integrin in the pathology following Semliki Forest virus infection. J Neuroimmunol (2000) 0.78
Inhibition of chronic relapsing experimental allergic encephalomyelitis in the mouse by the alkyl-lysophospholipid ET-18-OCH3. Int J Immunopharmacol (1991) 0.78
Space-time clustering of multiple sclerosis cases around birth. Acta Neurol Scand (1998) 0.78
The effect of cycloleucine on SFV A7(74) infection in mice. Br J Exp Pathol (1987) 0.78